| Year |
Citation |
Score |
| 2020 |
Srzentić K, Fornelli L, Tsybin YO, Loo JA, Seckler H, Agar JN, Anderson LC, Bai DL, Beck A, Brodbelt JS, van der Burgt YEM, Chamot-Rooke J, Chatterjee S, Chen Y, Clarke DJ, ... ... Wildburger NC, et al. Interlaboratory Study for Characterizing Monoclonal Antibodies by Top-Down and Middle-Down Mass Spectrometry. Journal of the American Society For Mass Spectrometry. PMID 32812765 DOI: 10.1021/Jasms.0C00036 |
0.444 |
|
| 2019 |
Paterson RW, Gabelle A, Lucey BP, Barthélemy NR, Leckey CA, Hirtz C, Lehmann S, Sato C, Patterson BW, West T, Yarasheski K, Rohrer JD, Wildburger NC, Schott JM, Karch CM, et al. SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases. Nature Reviews. Neurology. PMID 31222062 DOI: 10.1038/S41582-019-0222-0 |
0.645 |
|
| 2019 |
Bateman RJ, Mawuenyega KG, Wildburger NC. The structure of amyloid-β dimers in Alzheimer's disease brain: a step forward for oligomers. Brain : a Journal of Neurology. 142: 1168-1169. PMID 31032843 DOI: 10.1093/Brain/Awz082 |
0.496 |
|
| 2018 |
Scala F, Nenov MN, Crofton EJ, Singh AK, Folorunso O, Zhang Y, Chesson BC, Wildburger NC, James TF, Alshammari MA, Alshammari TK, Elfrink H, Grassi C, Kasper JM, Smith AE, et al. Environmental Enrichment and Social Isolation Mediate Neuroplasticity of Medium Spiny Neurons through the GSK3 Pathway. Cell Reports. 23: 555-567. PMID 29642012 DOI: 10.1016/J.Celrep.2018.03.062 |
0.731 |
|
| 2018 |
Wildburger NC, Gyngard F, Guillermier C, Patterson BW, Elbert D, Mawuenyega KG, Schneider T, Green K, Roth R, Schmidt RE, Cairns NJ, Benzinger TLS, Steinhauser ML, Bateman RJ. Amyloid-β Plaques in Clinical Alzheimer's Disease Brain Incorporate Stable Isotope Tracerand Exhibit Nanoscale Heterogeneity. Frontiers in Neurology. 9: 169. PMID 29623063 DOI: 10.3389/Fneur.2018.00169 |
0.513 |
|
| 2017 |
Wildburger NC, Esparza TJ, LeDuc RD, Fellers RT, Thomas PM, Cairns NJ, Kelleher NL, Bateman RJ, Brody DL. Diversity of Amyloid-beta Proteoforms in the Alzheimer's Disease Brain. Scientific Reports. 7: 9520. PMID 28842697 DOI: 10.1038/S41598-017-10422-X |
0.509 |
|
| 2017 |
Brody DL, Jiang H, Wildburger N, Esparza TJ. Non-canonical soluble amyloid-beta aggregates and plaque buffering: controversies and future directions for target discovery in Alzheimer's disease. Alzheimer's Research & Therapy. 9: 62. PMID 28818091 DOI: 10.1186/S13195-017-0293-3 |
0.341 |
|
| 2017 |
Hsu WJ, Wildburger N, Haidacher SJ, Nenov MN, Folorunso O, Singh AK, Chesson BC, Franklin WF, Cortez I, Sadygov RG, Dineley KT, Rudra J, Taglialatela G, Lichti CF, Denner L, et al. PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease. Experimental Neurology. PMID 28522250 DOI: 10.1016/J.Expneurol.2017.05.005 |
0.726 |
|
| 2016 |
Esparza TJ, Wildburger NC, Jiang H, Gangolli M, Cairns NJ, Bateman RJ, Brody DL. Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains. Scientific Reports. 6: 38187. PMID 27917876 DOI: 10.1038/srep38187 |
0.507 |
|
| 2016 |
Hsu WJ, Scala F, Nenov MN, Wildburger NC, Elferink H, Singh AK, Chesson CB, Buzhdygan T, Sohail M, Shavkunov AS, Panova NI, Nilsson CL, Rudra JS, Lichti CF, Laezza F. CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 26917740 DOI: 10.1096/Fj.201500161 |
0.737 |
|
| 2016 |
Wildburger NC, Esparza TJ, Cairns NJ, Bateman R, Brody DL. P1-100: Amyloid-Beta (Aβ) Isoforms and Ptms of Soluble Aβ Oligomers from Human Brain Alzheimer's & Dementia. 12: P439-P440. DOI: 10.1016/J.Jalz.2016.06.848 |
0.493 |
|
| 2015 |
Wildburger NC, Zhou S, Zacharias LG, Kroes RA, Moskal JR, Schmidt M, Mirzaei P, Gumin J, Lang FF, Mechref Y, Nilsson CL. Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts. Journal of Proteome Research. 14: 3932-9. PMID 26185906 DOI: 10.1021/Acs.Jproteome.5B00549 |
0.522 |
|
| 2015 |
Wildburger NC, Wood PL, Gumin J, Lichti CF, Emmett MR, Lang FF, Nilsson CL. ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts. Journal of Proteome Research. 14: 2511-9. PMID 25880480 DOI: 10.1021/Acs.Jproteome.5B00076 |
0.747 |
|
| 2015 |
Wildburger NC, Ali SR, Hsu WC, Shavkunov AS, Nenov MN, Lichti CF, LeDuc RD, Mostovenko E, Panova-Elektronova NI, Emmett MR, Nilsson CL, Laezza F. Quantitative proteomics reveals protein-protein interactions with fibroblast growth factor 12 as a component of the voltage-gated sodium channel 1.2 (nav1.2) macromolecular complex in Mammalian brain. Molecular & Cellular Proteomics : McP. 14: 1288-300. PMID 25724910 DOI: 10.1074/Mcp.M114.040055 |
0.716 |
|
| 2015 |
James TF, Nenov MN, Wildburger NC, Lichti CF, Luisi J, Vergara F, Panova-Electronova NI, Nilsson CL, Rudra JS, Green TA, Labate D, Laezza F. The Nav1.2 channel is regulated by GSK3. Biochimica Et Biophysica Acta. 1850: 832-44. PMID 25615535 DOI: 10.1016/J.Bbagen.2015.01.011 |
0.769 |
|
| 2015 |
Wildburger NC, Wood PL, Gumin J, Lichti CF, Emmett MR, Lang FF, Nilsson CL. ESI-MS/MS and MALDI-IMS localization reveal alterations in phosphatidic acid, diacylglycerol, and DHA in glioma stem cell xenografts Journal of Proteome Research. 14: 2511-2519. DOI: 10.1021/acs.jproteome.5b00076 |
0.727 |
|
| 2015 |
Lichti CF, Wildburger NC, Shavkunov AS, Mostovenko E, Liu H, Sulman EP, Nilsson CL. The proteomic landscape of glioma stem-like cells Eupa Open Proteomics. 8: 85-93. DOI: 10.1016/J.Euprot.2015.06.008 |
0.728 |
|
| 2015 |
Wildburger NC, Lichti CF, LeDuc RD, Schmidt M, Kroes RA, Moskal JR, Nilsson CL. Quantitative proteomics and transcriptomics reveals metabolic differences in attracting and non-attracting human-in-mouse glioma stem cell xenografts and stromal cells Eupa Open Proteomics. 8: 94-103. DOI: 10.1016/J.Euprot.2015.06.006 |
0.648 |
|
| 2014 |
Nilsson CL, Wildburger NC, Gumin J, Kroes RA, Moskal JR, Mechref Y, Lang FF. SC-24 * IMPROVEMENT OF HUMAN MESENCHYMAL STEM CELL HOMING IN DELIVERY OF THERAPEUTIC AGENTS TO GLIOMA STEM CELL XENOGRAFTS Neuro-Oncology. 16: v202-v202. DOI: 10.1093/Neuonc/Nou275.24 |
0.526 |
|
| 2013 |
Shavkunov AS, Wildburger NC, Nenov MN, James TF, Buzhdygan TP, Panova-Elektronova NI, Green TA, Veselenak RL, Bourne N, Laezza F. The fibroblast growth factor 14·voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3). The Journal of Biological Chemistry. 288: 19370-85. PMID 23640885 DOI: 10.1074/Jbc.M112.445924 |
0.762 |
|
| 2012 |
Wildburger NC, Laezza F. Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase. Frontiers in Molecular Neuroscience. 5: 80. PMID 22811658 DOI: 10.3389/Fnmol.2012.00080 |
0.697 |
|
| 2009 |
Wildburger NC, Lin-Ye A, Baird MA, Lei D, Bao J. Neuroprotective effects of blockers for T-type calcium channels. Molecular Neurodegeneration. 4: 44. PMID 19863782 DOI: 10.1186/1750-1326-4-44 |
0.38 |
|
| 2006 |
Wildburger NC, Day GS, Sigurdson W, Sullivan M, Peters A, Schmidt RE, Bateman RJ. P3-071: IN VIVO
STABLE ISOTOPE LABELING AND QUANTITATIVE MASS SPECTROMETRY IMAGING OF Aβ PLAQUE DEPOSITION AND TAUOPATHY IN HUMAN AD BRAIN Alzheimer's & Dementia. 14: P1091-P1092. DOI: 10.1016/J.Jalz.2018.06.1427 |
0.495 |
|
| Show low-probability matches. |
